Since September 2025, Claudia Hartmann has been responsible as Director International Sales & Partner Management for Engelhard Arzneimittel’s global sales strategy. With this move, the company signals its next growth phase.
On January 1, 2026, Franziska Erdle will succeed Dr. Sebastian Schmitz as ABDA CEO, bringing extensive association leadership experience.
On January 1, 2026, Andrea Bannert will assume the role of Editor-in-Chief of FOCUS Health, succeeding Andrea Hennis, who is retiring.
From September 1, 2025, Margit Pratschko will lead the pharmacy customer magazine My life alone – Silvia von Maydell is retiring.
Starting in September 2025, Dagmar Brandenstein will become the new Managing Director of bvitg Service GmbH and drive the strategic development of DMEA.
After nearly three years at the helm, Tobias Conrad is leaving cross-media marketer BCN for personal reasons, handing leadership to a dual management team.
Effective September 1, 2025, Dr. Carla Kriwet will succeed Dr. Hadi Saleh as CEO of the CeramTec Group. Saleh will join the Supervisory Board in January.
With Jean-Michel Quinot as new COO, AOP Health is strengthening its international leadership – with ambitious growth plans including U.S. market entry by 2030.
Nathan Licht joins the PEIX Health Group after three years at Capgemini and will now drive internal digitalization projects in close collaboration with management.
Haleon strengthens its leadership team with the appointment of Carl Haney as Chief R&D Officer. He will take on the role starting August 1, 2025.
Starting in October, Jörg Störmer will head the Procurement Management department at Klinikum Region Hannover, bringing extensive industry experience.
With Ellen Goel, the Life Science Factory welcomes a new Managing Director. She brings entrepreneurial spirit, experience, and passion for life sciences.
The Helmholtz Association has unanimously elected Sabine Helling-Moegen as its new Managing Director. She will take office on November 1, 2025, in Berlin.
Sigrun Kaiser will step down as CEO of Blue Ocean Entertainment AG in early 2026. Katrin Krauss and Max Müller will take over as managing directors.
Dr. Katja Nielsen takes the lead of Genmab Germany to drive market entry for innovative antibody therapies in one of Europe’s most important healthcare markets.
TME Pharma has appointed Diede van den Ouden as its new CEO. The leadership change marks a new phase in the biotech company’s fight against aggressive cancers.
Federal Health Minister Nina Warken speaks out against Rx discounts after a court ruling and calls for equal conditions for pharmacies.
Novo Nordisk appoints Maziar Mike Doustdar as new CEO – focusing on growth, innovation, and global expansion.
CompuGroup Medical announces the departure of Dr. Ulrich Thomé. CEO Daniel Gotthardt will temporarily lead the AIS DACH division.
Dirk Huefnagels will join LOBECO's executive board in August. The seasoned marketing strategist brings extensive expertise from both corporate and agency environments.
